Satoshi Moriya

587 total citations
31 papers, 305 citations indexed

About

Satoshi Moriya is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Satoshi Moriya has authored 31 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 14 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Satoshi Moriya's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). Satoshi Moriya is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). Satoshi Moriya collaborates with scholars based in Japan, China and United States. Satoshi Moriya's co-authors include Shin Maeda, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Katsuaki Tanaka, Akito Nozaki, Hiroyuki Fukuda, Tomohiro Ishii, Satoshi Morita and Masahiro Okada and has published in prestigious journals such as Gastroenterology, Radiology and Medicine.

In The Last Decade

Satoshi Moriya

29 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Moriya Japan 11 193 141 85 58 46 31 305
Denise N. Gansen United States 7 138 0.7× 72 0.5× 67 0.8× 51 0.9× 28 0.6× 8 272
Toyokazu Fukunaga Japan 11 285 1.5× 224 1.6× 40 0.5× 67 1.2× 46 1.0× 24 362
Zhi‐Cheng Jin China 11 146 0.8× 59 0.4× 54 0.6× 48 0.8× 29 0.6× 19 298
Cheng‐Qian Zhong China 9 139 0.7× 71 0.5× 47 0.6× 56 1.0× 77 1.7× 20 277
P Hilgard Germany 5 220 1.1× 62 0.4× 72 0.8× 75 1.3× 32 0.7× 6 309
Toshitaka Sugawara Japan 9 118 0.6× 87 0.6× 182 2.1× 98 1.7× 50 1.1× 24 304
Francesca Garuti Italy 6 144 0.7× 81 0.6× 98 1.2× 40 0.7× 61 1.3× 8 263
Jue Yang China 7 191 1.0× 90 0.6× 103 1.2× 174 3.0× 67 1.5× 9 331
Tomoya Kawase Japan 6 140 0.7× 122 0.9× 103 1.2× 69 1.2× 39 0.8× 22 298

Countries citing papers authored by Satoshi Moriya

Since Specialization
Citations

This map shows the geographic impact of Satoshi Moriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Moriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Moriya more than expected).

Fields of papers citing papers by Satoshi Moriya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Moriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Moriya. The network helps show where Satoshi Moriya may publish in the future.

Co-authorship network of co-authors of Satoshi Moriya

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Moriya. A scholar is included among the top collaborators of Satoshi Moriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Moriya. Satoshi Moriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kobayashi, Satoshi, Taito Fukushima, Makoto Ueno, et al.. (2022). A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma. BMC Cancer. 22(1). 517–517. 7 indexed citations
3.
Wang, Feiqian, Kazushi Numata, Makoto Chuma, et al.. (2021). The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma. Abdominal Radiology. 46(6). 2527–2539. 2 indexed citations
4.
5.
Wang, Feiqian, Kazushi Numata, Masahiro Okada, et al.. (2021). Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma. Quantitative Imaging in Medicine and Surgery. 11(6). 2521–2540. 11 indexed citations
6.
Nozaki, Akito, Makoto Chuma, Koji Hara, et al.. (2021). Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection. Medicine. 100(12). e25110–e25110. 4 indexed citations
7.
Ueno, Makoto, Satoshi Kobayashi, Manabu Morimoto, et al.. (2018). Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancer.. PubMed. 8(10). 2096–2105. 14 indexed citations
8.
Kobayashi, Satoshi, Makoto Ueno, Hiroki Hara, et al.. (2016). Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer. Oncology. 91(3). 117–126. 2 indexed citations
9.
Kobayashi, Satoshi, Makoto Ueno, Ryo Kameda, et al.. (2016). Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstruction. Pancreatology. 16(6). 1085–1091. 18 indexed citations
10.
Fukuda, Hiroyuki, Kazushi Numata, Satoshi Moriya, et al.. (2014). Hepatocellular Carcinoma: Concomitant Sorafenib Promotes Necrosis after Radiofrequency Ablation—Propensity Score Matching Analysis. Radiology. 272(2). 598–604. 27 indexed citations
11.
Takizawa, Kenji, Kazushi Numata, Masakazu Morimoto, et al.. (2013). Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma. European Journal of Radiology. 82(9). 1471–1480. 30 indexed citations
12.
Numata, Kazushi, Hiroyuki Fukuda, Haruo Miwa, et al.. (2013). Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. European Journal of Radiology. 83(1). 95–102. 31 indexed citations
13.
Moriya, Satoshi, Manabu Morimoto, Kazushi Numata, et al.. (2013). Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.. PubMed. 33(3). 997–1001. 18 indexed citations
14.
Morimoto, Manabu, Masaaki Kondo, Satoshi Moriya, et al.. (2013). Efficacy of chemoembolization for recurrent HCC after curative ablation therapy.. PubMed. 60(123). 395–99. 1 indexed citations
15.
Morimoto, Manabu, Kazushi Numata, Masaaki Kondo, et al.. (2012). Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study. European Journal of Radiology. 82(3). 497–503. 18 indexed citations
16.
Morimoto, Manabu, Kazushi Numata, Satoshi Moriya, et al.. (2012). Inflammation-based prognostic score for hepatocellular carcinoma patients on sorafenib treatment.. PubMed. 32(2). 619–23. 20 indexed citations
17.
Morimoto, Manabu, Kazushi Numata, Akito Nozaki, et al.. (2011). Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations. International Journal of Clinical Oncology. 17(4). 373–379. 26 indexed citations
18.
Kodama, Junichi, Mitsuhiro Takemoto, Narihito Seki, et al.. (2008). Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 18(6). 1300–1304. 6 indexed citations
19.
Iitaka, Kikuo, et al.. (2003). Long-term follow-up of type II membranoproliferative glomerulonephritis in two children. Clinical and Experimental Nephrology. 7(1). 58–62. 2 indexed citations
20.
Iitaka, Kikuo, et al.. (2001). Clinical course of lupus membranous glomerulonephritis in children. Clinical and Experimental Nephrology. 5(3). 153–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise N. Gansen Breakdown of academic impact, for papers by Toyokazu Fukunaga Breakdown of academic impact, for papers by Zhi‐Cheng Jin Breakdown of academic impact, for papers by Cheng‐Qian Zhong Breakdown of academic impact, for papers by P Hilgard Breakdown of academic impact, for papers by Toshitaka Sugawara Breakdown of academic impact, for papers by Francesca Garuti Breakdown of academic impact, for papers by Jue Yang Breakdown of academic impact, for papers by Tomoya Kawase
Rankless by CCL
2026